InsiderDB
Sign inStart free trial

Rep. Daniel S. Goldman sold Takeda Pharmaceutical Company Limited (TAK)

Rep. Daniel S. Goldman (D-NY-10) · $15K–$50K · traded Jul 10, 2023

Transaction
Sold
Amount
$15K–$50K
Owner
Not stated
Traded
Jul 10, 2023
Disclosed
Aug 13, 2023
Days to disclose
34
Asset type
Stock
As filed
Takeda Pharmaceutical Company Limited American Depositary Shares
Industry
Drug Manufacturers - Specialty & Generic · Healthcare
Official filing ↗All of Goldman's tradesAll Congress trades in TAK

Other trades in this filing

All of Goldman's trades →

Recent Congress trades in TAK

Company context for TAK

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. TAKCompany announcement·SEC EDGAR

    TAK: 6-K company filing

    Filed 6-K for an event or period dated 2026-10-29. Read the company report for its disclosures.

    Public: Oct 29, 2026, 6:49 AM EDTEvent / period: Oct 29, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. TAKCompany announcement·SEC EDGAR

    TAK: 6-K company filing

    Filed 6-K for an event or period dated 2026-10-29. Read the company report for its disclosures.

    Public: Oct 29, 2026, 6:33 AM EDTEvent / period: Oct 29, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. TAKCompany announcement·SEC EDGAR

    TAK: 6-K company filing

    Filed 6-K for an event or period dated 2026-09-14. Read the company report for its disclosures.

    Public: Sep 14, 2026, 6:25 AM EDTEvent / period: Sep 14, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.